BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15025902)

  • 1. The quest for well-being: a qualitative study of the experience of taking antipsychotic medication.
    Carrick R; Mitchell A; Powell RA; Lloyd K
    Psychol Psychother; 2004 Mar; 77(Pt 1):19-33. PubMed ID: 15025902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing the adherence of antipsychotic medication (Aripiprazole) in first-episode psychosis: findings from a grounded theory study.
    Hon A
    J Psychiatr Ment Health Nurs; 2012 May; 19(4):354-61. PubMed ID: 22404328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to antipsychotic medications.
    Perkins DO
    J Clin Psychiatry; 1999; 60 Suppl 21():25-30. PubMed ID: 10548139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The least worst option: user experiences of antipsychotic medication and lack of involvement in medication decisions in a UK community sample.
    Morant N; Azam K; Johnson S; Moncrieff J
    J Ment Health; 2018 Aug; 27(4):322-328. PubMed ID: 28857636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living with antipsychotic medication side-effects: the experience of Australian mental health consumers.
    Morrison P; Meehan T; Stomski NJ
    Int J Ment Health Nurs; 2015 Jun; 24(3):253-61. PubMed ID: 25529392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is it like to take antipsychotic medication? A qualitative study of patients with first-episode psychosis.
    Gray R; Deane K
    J Psychiatr Ment Health Nurs; 2016 Mar; 23(2):108-15. PubMed ID: 26914866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication.
    Moncrieff J; Azam K; Johnson S; Marston L; Morant N; Darton K; Wood N
    BMC Psychiatry; 2016 Jul; 16():205. PubMed ID: 27377549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
    Kao YC; Liu YP
    Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consumer strategies for coping with antipsychotic medication side effects.
    Meehan T; Stedman T; Wallace J
    Australas Psychiatry; 2011 Feb; 19(1):74-7. PubMed ID: 21303281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personal Accounts of Discontinuing Neuroleptic Medication for Psychosis.
    Geyt GL; Awenat Y; Tai S; Haddock G
    Qual Health Res; 2017 Mar; 27(4):559-572. PubMed ID: 26984364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder.
    Wong MM; Chen EY; Lui SS; Tso S
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):135-41. PubMed ID: 21983497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative study of medication-taking behaviour in primary care.
    Dowell J; Hudson H
    Fam Pract; 1997 Oct; 14(5):369-75. PubMed ID: 9472370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication management ability assessment: results from a performance-based measure in older outpatients with schizophrenia.
    Patterson TL; Lacro J; McKibbin CL; Moscona S; Hughs T; Jeste DV
    J Clin Psychopharmacol; 2002 Feb; 22(1):11-9. PubMed ID: 11799337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotics side effects' influence on stigma of mental illness: focus group study results.
    Novak L; Svab V
    Psychiatr Danub; 2009 Mar; 21(1):99-102. PubMed ID: 19270631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The subjective experiences of people who regularly receive depot neuroleptic medication in the community.
    Phillips L; McCann E
    J Psychiatr Ment Health Nurs; 2007 Sep; 14(6):578-86. PubMed ID: 17718731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicine taking decisions: schizophrenia in comparison to asthma and epilepsy.
    Marland GR; Cash K
    J Psychiatr Ment Health Nurs; 2005 Apr; 12(2):163-72. PubMed ID: 15788033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight and adherence to treatment in psychotic disorders.
    Kemp RA; David AS
    Br J Hosp Med; 1995 Sep 6-19; 54(5):222-7. PubMed ID: 8528530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.